Essential trace element alterations in amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 147, Issue 2, 1997, Pages 171-175

  Kapaki, Elisabeth ^a   Zournas, Christos ^a   Kanias, George ^a   Zambelis, Thomas ^a   Kakami, Afroditi ^a   Papageorgiou, Constantine ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Amyotrophic lateral sclerosis; Cerebrospinal fluid; Serum; SOD metabolism; Trace elements

Indexed keywords

COPPER; MAGNESIUM; MANGANESE; SUPEROXIDE DISMUTASE; TRACE ELEMENT; ZINC;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; COPPER; FEMALE; HUMANS; MAGNESIUM; MALE; MANGANESE; MIDDLE AGED; SPECTROPHOTOMETRY, ATOMIC; SUPEROXIDE DISMUTASE; TRACE ELEMENTS; ZINC;

EID: 0031569806     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)05334-8     Document Type: Article

References (34)

1. Beckman, J.S., Carson, M., Smith, C.D. and Koppenol, W.H. (1993) ALS, SOD and peroxynitrite. Nature, 364: 584.
2. Bowling, A.C., Schulz, J.B., Brown, R.H. Jr. and Beal, M.F. (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem., 61: 2322-2325.
3. Brooks, B.R., Sufit, R.L. and Peters, H.A. (1990) Cerebrospinal fluid lead, zinc and copper in amyotrophic lateral sclerosis. Increased CSF zinc in bulbar ALS patients following intravenous EDTA or TRH. In: F.C. Rose and F.H. Norris (Eds.), Amyotrophic Lateral Sclerosis. New Advances in Toxicology and Epidemiology, pp. 237-242. Smith-Gordon, London; Nishimura, Japan.
4. Carri, M.T., Battistoni, A., Polizio, F., Desideri, A. and Rotilio, G. (1994) Impaired copper binding by the H46R mutant of human Cu,Zn superoxide dismutase, involved in amyotrophic lateral sclerosis. FEBS Lett., 356: 314-316.
5. Deng, H.-X., Hentati, A., Tainer, J.A. et al. (1993) Amyotrophic lateral sclerosis and structural defects in Cu. Zn superoxide dismutase. Science, 261: 1047-1051.
6. Dexter, D.T., Wells, F.R., Agid, F.. Agid, Y., Lees, A.J., Jenner, P. and Marsden, C.D. (1987) Increased nigral iron content in postmortem parkinsonian brain. Lancet, 2(ii): 1219-1220.
7. Donaldson, J. (1987) The physiopathologic significance of manganese in brain: Its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology, 8: 451-462.
8. Gajdusec, D.C. (1984) Environmental factors provoking physiological changes which induce motor neuron disease and early neuronal aging in high incidence foci in the Western Pacific: Calcium deficiency-induced secondary hyperparathyroidism and resultant CNS disposition of calcium and other metallic cations as the cause of ALS and PD in high incidence foci. In: F.C. Rose (Ed.), Progress in Motor Disease. Pitman, Sevenoaks, Kent, pp. 44-69.
9. Garruto, R.M., Yanagihara, R. and Gajdusek, D.C. (1985) Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology, 35: 193-198.
10. Garruto, R.M. and Yase, Y. (1986) Neurodegenerative disorders of the Western Pacific: The search for mechanisms of pathogenesis. Trends Neurosci.. 9: 368-374.
11. Halliwell, B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem., 59: 1609-1623.
12. Hansen, S. and Ballantyne, J.P. (1978) A quantitative electrophysiological study of motor neuron disease. J. Neurol. Neurosurg. Psychiatry. 41: 773-783.
13. Hartmann, H.A. and Evenson, M.A. (1992) Deficiency of copper can cause neuronal degeneration. Med. Hypotheses, 38: 75-85.
14. Ince, P.G., Shaw, P.J., Candy, J.M., Mantle, D., Tandon, L., Ehmann. W.D. and Markesbery, W.R. (1994) Iron, Selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci. Lett., 182: 87-90.
15. Jones, C.T., Brock, D.J.H., Chancellor, A.M., Warlow, C.P. and Swingler, R.J. (1993) Cu/Zn superoxide dismutase (SOD1) mutations and sporadic amyotrophic lateral sclerosis. Lancet. 342: 1050-1051.
16. Kapaki, E., Segditsa, J. and Papageorgiou, C. (1989) Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders, Acta Neurol, Scand., 79: 373-378.
17. Kasarskis, E., (1990) Current status of toxic and essential metals in the pathogenesis of amyotrophic lateral sclerosis. In: R. Smith (Ed.), Handbook of Amyotrophic Lateral Sclerosis. Marcel Dekker, New York.
18. Khare, S.S., Ehmann, W.D., Kasarskis. E.J. and Markesbery, W.R. (1990) Trace element imbalances in amyotrophic lateral sclerosis. Neurotoxicology, 11: 521-532.
19. Kilburn, C.J. (1987) Manganese. malformations and motor disorders: findings in a manganese-exposed population. Neurotoxicology. 8: 421-430.
20. Kurlander, H.M. and Patten, B.M. (1979) Metals in spinal cord tissue of patients dying of motor neuron disease. Ann. Neurol., 6: 21-24.
21. Menkes, J.H., Alter, M., Steigleider, G.K. et al. (1962) A sexlinked recessive disorder with retardation of growth peculiar hair and focal cerebellar deterioration. Pediatrics. 29: 764.
22. Mitchell. J.D., East, B.W., Harris, I.A. and Pentland, B. (1991) Manganese, selenium and other trace elements in spinal cord, liver and bone in motor neuron disease. Eur. Neurol. 31: 7-11.
23. Mitchell, J.D., Harris, I.A., East, B.W. and Pentland, B. (1984) Trace elements in cerebrospinal fluid in motor neuron disease. Br. Med. J., 288: 1791-1792.
24. Mitchell, J.D., Harris, I.A., East, B.W. et al. (1985) Cerebrospinal fluid trace elements in motor neurone disease - cobalt content is reduced. In: C.F. Mills (Ed.), Trace Element Metabolism in Man and Animals, Vol. 5, Commonwealth Agricultural Bureau. Slough, pp. 826-830.
25. Mitchell, J.D., East, B.W., Harris, I.A., Prescott, R.J. and Pentland, B. (1986) Trace elements in the spinal cord and other tissues in motor neuron disease. J. Neurol. Neurosurg. Psychiatry, 49: 211-215.
26. Mitchell, J.D. (1987) Heavy metals and trace elements in amyotrophic lateral sclerosis. Neurol. Clin., 5: 43-60.
27. Mitchell, J.D. (1989) Trace elements, neurological disease and amyotrophic lateral sclerosis. In: G. Chazot et al. (Eds), Current Trends in Trace Elements Research. Smith-Gordon, London.
28. Miyata. S., Nakamura, S., Nagata, H. et al. (1983) Increased manganese level in spinal cord of amyotrophic lateral sclerosis determined by radiochemical neutron activation analysis. J. Neurol. Sci., 61: 283-293.
29. Nagata, H., Miyata, S., Nacamura, S., Kameyama, N. and Katsui, Y. (1985) Heavy metal concentration in blood cells in patients with amyotrophic lateral sclerosis. J. Neurol. Sci., 67: 173-178.
30. Papageorgiou, C.Th., Libitaki, G.S., Kapaki. E.N., Zournas, Ch.P. and Segditsa, J. (1993) Amino acid concentration in the cerebrospinal fluid in amyotrophic lateral sclerosis. Med. Sci. Res., 21: 561-562.
31. Plaitakis, A. and Shashidharan, P. (1995) Amyotrophic lateral sclerosis, glutamate and oxidative stress. In: F.E. Bloom and D.J. Kupfer (Eds), Psychopharmacology. The Fourth Generation of Progress, Ch. 136, Raven Press, New York.
32. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D.. Goto, J., O'Regan, J.P., Deng, H-X., Rahmani, Z., Krizus. A., McKenna-Yasek, D., Cayabyab, A., Gaston, S.M., Berger, R., Tanzi, R.E., Halperin, J.J., Herzfeldt, B., Van den Bergh, R., Hung, W.Y., Bird. T., Deng, G., Mulder, D.W., Smyth, C., Laing, N.G., Soriano, E., Pericak-Vance, M.A., Haines, J., Rouleau, G.A., Gusella, J.S., Horvitz, H.R. and Brown, R.H. Jr. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362: 59-62.
33. Wiedau-Pazos, M., Goto, J.J., Rabizadeh, S., Gralla, E.B., Roe, J.A., Lee, M.K., Valentine, J.S. and Bredesen, D.E. (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science, 271: 515-518.
34. Yase. Y. (1977) The basic process of amyotrophic lateral sclerosis as reflected in Kii Peninsula and Guam. In: W.A. Den Hartog Jager, G.M. Bruyn and A.P.J. Hejistee (Eds), Proceedings of 11th World Congress of Neurology, Amsterdam, pp. 413-427.